BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

636 related articles for article (PubMed ID: 9322945)

  • 1. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
    Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
    Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the hypothalamo-pituitary-adrenal axis by the growth hormone (GH) secretagogue, GH-releasing peptide-6, in rats.
    Thomas GB; Fairhall KM; Robinson IC
    Endocrinology; 1997 Apr; 138(4):1585-91. PubMed ID: 9075719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats.
    Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF
    Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat.
    Thomas GB; Bennett PA; Carmignac DF; Robinson IC
    Growth Horm IGF Res; 2000 Feb; 10(1):45-52. PubMed ID: 10753592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of 14-day infusions of growth hormone and/or insulin-like growth factor I on the obesity of growing Zucker rats.
    Dubuis JM; Deal C; Tsagaroulis P; Clark RG; Van Vliet G
    Endocrinology; 1996 Jul; 137(7):2799-806. PubMed ID: 8770900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
    Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into a role of GH secretagogues in reversing the age-related decline in the GH/IGF-I axis.
    Frutos MG; Cacicedo L; Fernández C; Vicent D; Velasco B; Zapatero H; Sánchez-Franco F
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1140-52. PubMed ID: 17684105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats.
    Tschöp M; Flora DB; Mayer JP; Heiman ML
    Obes Res; 2002 Oct; 10(10):991-9. PubMed ID: 12376579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth responses in a mutant dwarf rat to human growth hormone and recombinant human insulin-like growth factor I.
    Skottner A; Clark RG; Fryklund L; Robinson IC
    Endocrinology; 1989 May; 124(5):2519-26. PubMed ID: 2707163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of impaired growth hormone secretion in genetically obese Zucker rats: roles of growth hormone-releasing factor and somatostatin.
    Tannenbaum GS; Lapointe M; Gurd W; Finkelstein JA
    Endocrinology; 1990 Dec; 127(6):3087-95. PubMed ID: 1979030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The positive effects of growth hormone-releasing peptide-6 on weight gain and fat mass accrual depend on the insulin/glucose status.
    Granado M; García-Cáceres C; Frago LM; Argente J; Chowen JA
    Endocrinology; 2010 May; 151(5):2008-18. PubMed ID: 20219977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic basis for the diabetogenic action of growth hormone in the obese (ob/ob) mouse.
    Cameron CM; Kostyo JL; Adamafio NA; Dunbar JC
    Endocrinology; 1987 Apr; 120(4):1568-75. PubMed ID: 3549265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes.
    Sjöberg A; Oscarsson J; Olofsson SO; Edén S
    Endocrinology; 1994 Oct; 135(4):1415-21. PubMed ID: 7925103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humans.
    Gianotti L; Maccario M; Lanfranco F; Ramunni J; Di Vito L; Grottoli S; Muller EE; Ghigo E; Arvat E
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3604-8. PubMed ID: 11061509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free fatty acids activate the hypothalamic-pituitary-adrenocortical axis in rats.
    Widmaier EP; Rosen K; Abbott B
    Endocrinology; 1992 Nov; 131(5):2313-8. PubMed ID: 1330498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mechanism of hypothalamo-pituitary-adrenal (HPA) axis and neuronal changes after adrenalectomy in type 2 diabetes.
    Yi SS; Hwang IK; Shin JH; Choi JH; Lee CH; Kim IY; Kim YN; Won MH; Park IS; Seong JK; Yoon YS
    J Chem Neuroanat; 2010 Oct; 40(2):130-9. PubMed ID: 20472052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of corticotropin and growth hormone releasing hormones on their respective secretory axes in chronic hemodialysis patients before and after correction of anemia with recombinant human erythropoietin.
    Ramirez G; Bittle PA; Sanders H; Rabb HA; Bercu BB
    J Clin Endocrinol Metab; 1994 Jan; 78(1):63-9. PubMed ID: 8288716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial leptin restoration increases hypothalamic-pituitary-adrenal activity while diminishing weight loss and hyperphagia in streptozotocin diabetic rats.
    Akirav EM; Chan O; Inouye K; Riddell MC; Matthews SG; Vranic M
    Metabolism; 2004 Dec; 53(12):1558-64. PubMed ID: 15562400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of pituitary-adrenal responsiveness between insulin tolerance test and growth hormone-releasing peptide-2 test: a pilot study.
    Kano T; Sugihara H; Sudo M; Nagao M; Harada T; Ishizaki A; Nakajima Y; Tanimura K; Okajima F; Tamura H; Ishii S; Shibasaki T; Oikawa S
    Peptides; 2010 Apr; 31(4):657-61. PubMed ID: 20045717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.